Leadership Team

Saundra Pelletier

Saundra Pelletier

Chief Executive Officer

Saundra Pelletier has served as Chief Executive Officer, President and Executive Director of Evofem Biosciences since February 2015. Ms. Pelletier has been responsible for the company’s growth and evolution, and she led Evofem’s transition to the public market in January 2018 (NASDAQ: EVFM).

Ms. Pelletier has assembled an impressive team of seasoned pharmaceutical professionals that have a deep understanding of the women’s healthcare market and what women want, and she attracted new investor capital. She has also led multiple equity financing rounds which have raised over $491 million.

Read More
something something
something something
Jay File

Jay File

Chief Financial Officer

Mr. File has served as Evofem Biosciences’ Chief Financial Officer since April 2015. Mr. File has approximately 25 years of diverse accounting and finance experience within a variety of both public and private biotechnology and biopharmaceutical companies.

Most recently, Mr. File provided executive financial and accounting oversight services to various biotechnology companies in San Diego, California, assisting in their initial public offering process and helping to establish and improve their accounting and finance operations as publicly-traded entities.

Read More
Alex Fitzpatrick

Alex Fitzpatrick

Executive Vice President,
General Counsel & Secretary

Mr. Fitzpatrick has served as the Executive Vice President, General Counsel and Secretary of Evofem Biosciences since October 2017. Mr. Fitzpatrick is responsible for our corporate governance, legal, corporate development, intellectual property and risk management functions.

Prior to joining Evofem, Mr. Fitzpatrick served as Chief Legal Officer of Kyriba Corporation from 2014 to 2015 and Senior Vice President, General Counsel, Compliance Officer and Secretary of Verenium Corporation, a publicly traded biotechnology company from 2010 to 2014.

Read More